摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

((4S,6R)-6-(2-tert-butoxy-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl benzoate | 131666-50-7

中文名称
——
中文别名
——
英文名称
((4S,6R)-6-(2-tert-butoxy-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl benzoate
英文别名
(4R-cis)-6-[(benzoyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid, 1,1-dimethylethyl ester;(4R-cis)-6-[(benzoyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid,1,1-dimethylethyl ester;2-[(4R,6S)-2,2-dimethyl-6-benzoyloxymethyl-1,3-dioxan-4-yl]acetic tert-butyl ester;tert.-butyl (3R,5S)-6-benzoyloxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate;2-[(4R, 6S)-2,2-dimethyl-6-benzoyloxymethyl-1,3-dioxan-4-yl]acetic tert-butyl ester;[(4S,6R)-2,2-dimethyl-6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,3-dioxan-4-yl]methyl benzoate
((4S,6R)-6-(2-tert-butoxy-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl benzoate化学式
CAS
131666-50-7
化学式
C20H28O6
mdl
——
分子量
364.439
InChiKey
KHHRHONIHYEAHX-CVEARBPZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    26
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    71.1
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ((4S,6R)-6-(2-tert-butoxy-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl benzoatesodium hypochlorite2,2,6,6-四甲基哌啶氧化物4-甲基苯磺酸吡啶碳酸氢钠potassium carbonate溶剂黄146 、 potassium bromide 作用下, 以 四氢呋喃甲醇二氯甲烷二甲基亚砜 为溶剂, 反应 16.0h, 生成 tert-butyl-2((4R,6S)-6-{(E)-2-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfon-amido)-pyrimidin-5-yl]-vinyl}-2-phenyl-[1,3]dioxan-4-yl)acetate
    参考文献:
    名称:
    스타틴의 중간체, 이의 제조방법 및 이를 이용한 로수바스타틴의 제조방법
    摘要:
    本发明提供了一种制备洛索巴斯汀的关键中间体(化学式IV)的新型制备方法,以及用于该制备方法的新型中间体和利用该中间体制备洛索巴斯汀盐酸盐的方法。本发明的新型中间体可以在温和条件下高纯度和高产率地制备,从而可以简单、高效地大规模生产洛索巴斯汀的中间体和洛索巴斯汀盐酸盐,而无需复杂的工艺。
    公开号:
    KR20160126700A
  • 作为产物:
    描述:
    (4R-Cis)-6-羟甲基-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯苯甲酰氯吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 1.5h, 以88%的产率得到((4S,6R)-6-(2-tert-butoxy-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl benzoate
    参考文献:
    名称:
    스타틴의 중간체, 이의 제조방법 및 이를 이용한 로수바스타틴의 제조방법
    摘要:
    本发明提供了一种制备洛索巴斯汀的关键中间体(化学式IV)的新型制备方法,以及用于该制备方法的新型中间体和利用该中间体制备洛索巴斯汀盐酸盐的方法。本发明的新型中间体可以在温和条件下高纯度和高产率地制备,从而可以简单、高效地大规模生产洛索巴斯汀的中间体和洛索巴斯汀盐酸盐,而无需复杂的工艺。
    公开号:
    KR20160126700A
点击查看最新优质反应信息

文献信息

  • Process for the production of 3,5,6-trihydroxyhexanoic acid derivative
    申请人:Kanegafuchi Chemical Industry Co., Ltd.
    公开号:US04983759A1
    公开(公告)日:1991-01-08
    A compound of a 3,5,6-trihydroxyhexanoic acid derivative of the formula: ##STR1## wherein P.sup.1 and P.sup.2 are independently hydrogen atoms or hydroxy-protecting groups, or together form a ring, and R is an alkyl group is effectively prepared by a process comprising steps of: reacting a butyronitrile derivative of the formula: ##STR2## wherein P.sup.1 and P.sup.2 are the same as defined above with an .alpha.-haloacetate of the formula: X--CH.sub.2 --COOR (III) wherein X is a halogen atom, and R is the same as defined above in the presence of a metallic catalyst selected from the group consisting zinc and zinc-copper to form a keto acid derivative of the formula: ##STR3## wherein P.sup.1, P.sup.2 and R are the same as defined above, and then reducing the obtained keto-acid derivative of the formula (IV).
    一种化合物,其为3,5,6-三羟基己酸衍生物,化学式如下:##STR1## 其中P1和P2分别是氢原子或羟基保护基,或者一起形成一个环,R为烷基基团,通过以下步骤有效制备:将以下化学式的丁腈衍生物:##STR2## 其中P1和P2的定义与上述相同,与以下化学式的α-卤代乙酸酯:X--CH2--COOR (III) 反应,其中X为卤素原子,R的定义与上述相同,在选择自锌和锌-铜组成的金属催化剂存在下,形成以下酮酸衍生物:##STR3## 其中P1、P2和R的定义与上述相同,然后还原得到的酮酸衍生物(IV)。
  • Application of chiral 2-isoxazoline for the synthesis of <i>syn</i>-1,3-diol analogs
    作者:Juanjuan Feng、Tianyu Li、Jiaxin Zhang、Peng Jiao
    DOI:10.3762/bjoc.15.179
    日期:——

    The asymmetric cycloaddition of TIPS nitronate catalyzed by “Cu(II)-bisoxazoline” gave the 2-isoxazoline product in 95% yield, which was converted into tert-butyl (3S,5R)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate in 14 steps through a β-hydroxy ketone.

    TIPS硝酸酯的不对称环加成反应在“Cu(II)-双噁唑啉”催化下,产率为95%得到2-异噁唑醇产物,经过14步转化成(3S,5R)-6-羟基-3,5-O-异丙基-3,5-二羟基己酸叔丁酯,中间通过β-羟基酮。
  • Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives
    申请人:Nishiyama Akira
    公开号:US20050080277A1
    公开(公告)日:2005-04-14
    The present invention is to provide a production technology by which an optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivative, which are of value as pharmaceutical intermediates, can be produced from inexpensive and readily available starting materials without using any extraordinary equipment such as an ultra-low-temperature reactor. The present invention is a production process of an optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivative which comprises reacting an enolate, prepared by permitting a base or a 0-valent metal to act on an acetic acid ester derivative with (S)-β-hydroxy-γ-butyrolactone at a temperature not lower than −30° C. to give a dihydroxyoxohexanoic acid derivative, treating the same with an acylating agent in the presence of a base to produce a dihydroxyoxohexanoic acid monoacyl derivative, reducing this compound with a microorganism to produce a trihydroxyhexanoic acid monoacyl derivative, treating this compound with an acetal-forming reagent in the presence of an acid catalyst to produce an acyloxymethyldioxanylacetic acid derivative, and finally, subjecting this compound to solvolysis in the presence of a base.
    本发明旨在提供一种生产技术,通过该技术可以从廉价且易得的起始材料中生产出具有药物中间体价值的光学活性2-[6-(羟甲基)-1,3-二氧杂环戊-4-基]乙酸衍生物,而无需使用任何特殊设备,如超低温反应器。本发明是一种光学活性2-[6-(羟甲基)-1,3-二氧杂环戊-4-基]乙酸衍生物的生产过程,包括将碱或0价金属作用于乙酸酯衍生物制备出的烯醇,与(S)-β-羟基-γ-丁内酯在不低于-30℃的温度下反应,得到二羟基氧代己酸衍生物,用酰化剂在碱的存在下处理,以产生二羟基氧代己酸单酰衍生物,用微生物还原该化合物以产生三羟基己酸单酰衍生物,用酸催化剂存在下的缩醛试剂处理该化合物,以产生酰氧甲基二氧杂环己酸衍生物,最后,在碱的存在下进行溶剂解离。
  • Process for the preparation of 1,3-dioxane derivatives useful in the
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US05594153A1
    公开(公告)日:1997-01-14
    A novel, overall process for the preparation of a compound of the formula I: ##STR1## where R.sup.1 and R.sup.2 are each independently hydrogen, an alkyl group, a cycloalkyl group, an aryl group or, taken together with the carbon atom to which they are attached, form a cycloalkyl group; and R.sup.3 is hydrogen, an alkyl group, or an aryl group, or salts thereof, useful as intermediates in the preparation of HMG-CoA reductase inhibitors; novel methods within the overall process; and novel intermediates produced by those methods.
    一种用于制备公式I化合物的新型全过程:##STR1## 其中,R.sup.1和R.sup.2分别独立地表示氢、烷基、环烷基、芳基或与它们连接的碳原子形成环烷基;R.sup.3表示氢、烷基或芳基,或其盐,可用作制备HMG-CoA还原酶抑制剂的中间体;该全过程中的新型方法;以及由这些方法产生的新型中间体。
  • PROCESS FOR PREPARING OPTICALLY ACTIVE 2- 6-(HYDROXY-METHYL)-1,3-DIOXAN-4-YL]ACETIC ACID DERIVATIVES
    申请人:KANEKA CORPORATION
    公开号:EP1288213A1
    公开(公告)日:2003-03-05
    The present invention is to provide a production technology by which an optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivative, which are of value as pharmaceutical intermediates, can be produced from inexpensive and readily available starting materials without using any extraordinary equipment such as an ultra-low-temperature reactor. The present invention is a production process of an optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivative    which comprises reacting an enolate, prepared by permitting a base or a 0-valent metal to act on an acetic acid ester derivative with (S)-β-hydroxy-γ-butyrolactone at a temperature not lower than -30°C to give a dihydroxyoxohexanoic acid derivative,    treating the same with an acylating agent in the presence of a base to produce a dihydroxyoxohexanoic acid monoacyl derivative,    reducing this compound with a microorganism to produce a trihydroxyhexanoic acid monoacyl derivative,    treating this compound with an acetal-forming reagent in the presence of an acid catalyst to produce an acyloxymethyldioxanylacetic acid derivative, and    finally, subjecting this compound to solvolysis in the presence of a base.
    本发明旨在提供一种生产技术,通过该技术,无需使用超低温反应器等任何特殊设备,即可从廉价易得的起始材料中生产出具有光学活性的 2-[6-(羟甲基)-1,3-二氧杂环戊烷-4-基]乙酸衍生物,该衍生物具有医药中间体的价值。 本发明是一种具有光学活性的 2-[6-(羟甲基)-1,3-二氧杂环戊烷-4-基]乙酸衍生物的生产工艺。 其中包括在不低于-30℃的温度下,将通过允许碱或 0 价金属作用于乙酸酯衍生物而制备的烯醇与(S)-β-羟基-γ-丁内酯反应,得到二羟基氧代己酸衍生物、 在碱存在下,用酰化剂处理该衍生物,生成二羟基氧代己酸单酰基衍生物、 用微生物还原该化合物,生成三羟基己酸单乙酰衍生物、 在酸催化剂存在下,用乙缩醛形成试剂处理该化合物,生成酰氧基甲基二氧杂环乙酸衍生物,以及 最后,使该化合物在碱存在下发生溶解反应。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐